[Therapeutic application of cerebral metabolism enhancers to Alzheimer's disease and their limitations].
Hasegawa
K
K
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000378:metabolism; D001921:Brain / Q000378:metabolism*; D004734:Energy Metabolism / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D010101:Oxygen Consumption / Q000187:drug effects; D010205:Pantothenic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use
C016030:pantogab; D010205:Pantothenic Acid; D005680:gamma-Aminobutyric Acid